Levels of Evidence

As more and more genetic variants are linked to disease risk, Geoffrey Ginsburg, director of genomic medicine at Duke University, argues in Nature that "there needs to be an efficient way to evaluate whether genetic information leads to better health care."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Big Three

What Does It Mean?

Going Well

Staying Well

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.